FJ

Felix J. Baker

Director

Xenon Pharmaceuticals

Roles

Managing Member, Baker Brothers Investments (Board Member)atKodiak Sciences

Therapeutic Areas

Xenon Pharmaceuticals Pipeline

DrugIndicationPhase
XEN1101Major Depressive Disorder (MDD)Phase 3
XEN496 (NBI-921352)KCNQ2 Developmental and Epileptic EncephalopathyPhase 2/3
XEN053Undisclosed TargetPreclinical